Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.
about
Evidence for restriction of ancient primate gammaretroviruses by APOBEC3 but not TRIM5alpha proteinsNatural polymorphisms in human APOBEC3H and HIV-1 Vif combine in primary T lymphocytes to affect viral G-to-A mutation levels and infectivityReconstitution of an infectious human endogenous retrovirusPopulation stratification of a common APOBEC gene deletion polymorphismAntiretroelement activity of APOBEC3H was lost twice in recent human evolutionSole copy of Z2-type human cytidine deaminase APOBEC3H has inhibitory activity against retrotransposons and HIV-1Human and rhesus APOBEC3D, APOBEC3F, APOBEC3G, and APOBEC3H demonstrate a conserved capacity to restrict Vif-deficient HIV-1The localization of APOBEC3H variants in HIV-1 virions determines their antiviral activityHIV-1 Vif versus the APOBEC3 cytidine deaminases: an intracellular duel between pathogen and host restriction factorsHIV-1 Vif, APOBEC, and intrinsic immunityHuman cytidine deaminase APOBEC3H restricts HIV-1 replicationThe range of human APOBEC3H sensitivity to lentiviral Vif proteinsPolymorphisms and splice variants influence the antiretroviral activity of human APOBEC3HA single amino acid difference in human APOBEC3H variants determines HIV-1 Vif sensitivityIdentification of APOBEC3DE as another antiretroviral factor from the human APOBEC familyAll APOBEC3 family proteins differentially inhibit LINE-1 retrotranspositionMultiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them allEvolutionary conflicts between viruses and restriction factors shape immunitySuppression of APOBEC3-mediated restriction of HIV-1 by VifCircadian clocks in mouse and human CD4+ T cellsA naturally occurring bovine APOBEC3 confers resistance to bovine lentiviruses: implication for the co-evolution of bovids and their lentivirusesIntrinsic immunity against retrotransposons by APOBEC cytidine deaminasesAn ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammalsPromiscuity and the rate of molecular evolution at primate immunity genesAPOBEC3G: an intracellular centurionHypermutation of an ancient human retrovirus by APOBEC3GThe Role of the Antiviral APOBEC3 Gene Family in Protecting Chimpanzees against Lentiviruses from MonkeysDiscordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals.Reduced APOBEC3H variant anti-viral activities are associated with altered RNA binding activities.Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein.APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.Demonstration of a novel HIV-1 restriction phenotype from a human T cell lineThe artiodactyl APOBEC3 innate immune repertoire shows evidence for a multi-functional domain organization that existed in the ancestor of placental mammals.Distinct determinants in HIV-1 Vif and human APOBEC3 proteins are required for the suppression of diverse host anti-viral proteinsGenetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G.Are viruses inhibited by APOBEC3 molecules from their host species?Functions and regulation of the APOBEC family of proteinsPositive selection of primate genes that promote HIV-1 replication.Leveraging APOBEC3 proteins to alter the HIV mutation rate and combat AIDS.Host restriction of murine gammaherpesvirus 68 replication by human APOBEC3 cytidine deaminases but not murine APOBEC3.
P2860
Q21131588-EB4FA835-CB16-4EE1-AB89-FFE6867F4113Q21144862-36DD2F8F-430D-4007-A057-4B336D7BE36DQ21559512-24211A0D-46C8-4EAD-BA7F-CDF9283F9B73Q21563457-BD03E193-8433-4117-8DA6-284A3E6DAEF5Q24311460-030DAC86-EC26-4D2C-A309-DC7115D1FE7EQ24317568-1AF5B384-4952-4B13-9CA8-6502A030FC53Q24321636-7F1E4A95-E4CD-459C-8C7F-6A950A3EDAC5Q24596322-B4B544BD-05C5-4FCD-9068-FAD6DAE33F76Q24619114-0E58EACD-B1B7-45BC-80E7-61B3AC028109Q24647833-6DEB9DA3-8512-49F4-8E49-5B6660958EABQ24653682-E7DC4AF9-A8DB-4E17-BD87-40D674423332Q24653931-99EAA6C7-6D2A-4038-ABE6-B3B764D0520FQ24655418-95A382EE-EADC-4EB4-8CA0-120B605F9088Q24656551-12A837A3-28AA-47B9-8592-192D8E5BD569Q24670173-FBCEFFC7-3FC1-4711-A215-75BCA5C997FCQ24675735-78F78A06-B19F-4CC2-BCA4-D8BC816898B4Q26823568-2E5F1330-C9D2-487B-B90D-CB924175D081Q27022032-A8A8D21F-67A9-40F6-8D56-C5BF4E0B7B39Q27025150-EEBAC987-3DDD-41BB-A836-D10FF9CEB5DCQ27310277-CC1FD70F-70EB-4065-9298-00288D55EE7DQ28598363-0240DB1C-A5FC-45B9-8213-13CEEEAAC080Q28708757-E10E908B-A980-4A2F-B53A-B903C3A99A50Q28713968-C429D40A-A2A6-4E86-AD49-EA4C136419B6Q28749670-6B7CE8ED-C977-46C3-8FFC-4A0D395649C0Q28754989-7B72ED69-0A08-4474-8B5D-5C4FDC9F21C7Q28757351-168ABB2B-9AC2-4B4F-B81E-CAE7AC7ABB57Q30379417-30E097C3-3CDF-4E51-B4A7-83891F146C26Q30839843-B8BDB588-3845-476A-88FE-0E3D1248A59EQ31078477-5EF00E8F-0089-4FE4-AE57-17B9DB052F5BQ33316824-D2196268-D52F-4E1F-85B9-FCFB2CFC5AFEQ33349452-65C14574-280E-4BD5-AC1F-1C927AC9973EQ33355942-9D4BF98B-F4DC-402A-8540-1956072818C3Q33385376-7D3ACBC9-200D-459F-B266-3D14FAC6B192Q33393637-995FEC66-90EB-4952-8D1C-2DEFEC43B670Q33402907-C1CFFF5E-4CDC-42D8-B44A-FF081038CC86Q33434458-F40A6A5A-279F-46C7-9994-A0D4C1DFE89CQ33595661-80684D6C-7A91-4783-9CD5-3C2D91DE7932Q33637979-84489B54-7A0A-4D91-ACE7-9100A0564FB4Q33654949-0B437FF4-0FB3-4BEE-B2CE-E6F545152207Q33677823-54CC2534-F496-46C4-A85E-67F1406096C4
P2860
Adaptive evolution and antiviral activity of the conserved mammalian cytidine deaminase APOBEC3H.
description
2006 nî lūn-bûn
@nan
2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Adaptive evolution and antivir ...... an cytidine deaminase APOBEC3H
@nl
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@ast
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en-gb
type
label
Adaptive evolution and antivir ...... an cytidine deaminase APOBEC3H
@nl
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@ast
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en-gb
prefLabel
Adaptive evolution and antivir ...... an cytidine deaminase APOBEC3H
@nl
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@ast
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en-gb
P2860
P921
P3181
P1433
P1476
Adaptive evolution and antivir ...... n cytidine deaminase APOBEC3H.
@en
P2093
Julie A Kerns
Molly OhAinle
P2860
P304
P3181
P356
10.1128/JVI.80.8.3853-3862.2006
P407
P577
2006-04-01T00:00:00Z